Sphingosine 1-phosphate Receptor Modulator [EPC]

Sphingosine 1-phosphate Receptor Modulator [EPC] was reported 13876 times

Drugs of the Sphingosine 1-phosphate Receptor Modulator [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 OSSEOUS CRYPTOCOCCOSIS 14 0.6667
1 CONCENTRIC SCLEROSIS 6 0.4000
2 HAEMORRHAGIC ADRENAL INFARCTION 6 0.3750
3 TUMEFACTIVE MULTIPLE SCLEROSIS 32 0.1882
4 CRYPTOCOCCAL MENINGOENCEPHALITIS 21 0.1603
5 GAIT SPASTIC 54 0.1574
6 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 170 0.1362
7 CD30 EXPRESSION 6 0.1333
8 EXPANDED DISABILITY STATUS SCALE 10 0.1333
9 RELAPSING-REMITTING MULTIPLE SCLEROSIS 107 0.1238
10 CRYPTOCOCCAL CUTANEOUS INFECTION 18 0.0989
11 NEUROCRYPTOCOCCOSIS 6 0.0968
12 NEEDLE FATIGUE 38 0.0832
13 ENCHONDROMATOSIS 7 0.0814
14 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 16 0.0773
15 LYMPHOMATOID PAPULOSIS 21 0.0717
16 MALIGNANT MELANOMA STAGE 0 14 0.0670
17 CONGENITAL MUSCULOSKELETAL DISORDER OF LIMBS 7 0.0667
18 JANUS KINASE 2 MUTATION 6 0.0659
19 RELAPSING MULTIPLE SCLEROSIS 18 0.0596
20 CONGENITAL NEUROLOGICAL DISORDER 6 0.0513
21 ENZYME LEVEL ABNORMAL 7 0.0500
22 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 94 0.0500
23 LYMPHOPENIA 685 0.0484
24 MOLLUSCUM CONTAGIOSUM 26 0.0481
25 MULTIPLE SCLEROSIS PSEUDO RELAPSE 16 0.0472
26 VISCERAL LEISHMANIASIS 34 0.0471
27 DYSMETRIA 26 0.0430
28 MENINGITIS CRYPTOCOCCAL 73 0.0417
29 ELECTROCARDIOGRAM QT SHORTENED 12 0.0396
30 SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED 10 0.0394
31 JC POLYOMAVIRUS TEST POSITIVE 45 0.0384
32 MONKEYPOX 10 0.0362
33 LYMPHOCYTE COUNT ABNORMAL 39 0.0346
34 CHEST WALL MASS 9 0.0346
35 CRYPTOCOCCOSIS 55 0.0337
36 LYMPHOCYTE COUNT DECREASED 576 0.0326
37 UPPER MOTOR NEURONE LESION 7 0.0318
38 HERPES ZOSTER REACTIVATION 8 0.0305
39 ELECTROCARDIOGRAM PR SHORTENED 6 0.0286
40 VACCINATION FAILURE 46 0.0276
41 MONOPARESIS 49 0.0271
42 PARAPARESIS 45 0.0252
43 DRUG DOSE TITRATION NOT PERFORMED 44 0.0240
44 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 7 0.0239
45 TRANSIENT TACHYPNOEA OF THE NEWBORN 9 0.0227
46 MACULAR OEDEMA 127 0.0226
47 OPHTHALMOPLEGIA 34 0.0215
48 CHOROIDITIS 8 0.0214
49 HER2 POSITIVE BREAST CANCER 8 0.0213
50 PAPILLOMA VIRAL INFECTION 35 0.0212
51 JC VIRUS INFECTION 33 0.0206
52 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 96 0.0192
53 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 158 0.0191
54 LOSS OF PROPRIOCEPTION 6 0.0186
55 DRUG TITRATION ERROR 48 0.0186
56 LIMBIC ENCEPHALITIS 5 0.0181
57 ANOGENITAL WARTS 16 0.0179
58 PLEOCYTOSIS 10 0.0172
59 HYPERTONIC BLADDER 49 0.0169
60 PHAEOHYPHOMYCOSIS 8 0.0167
61 PYRAMIDAL TRACT SYNDROME 7 0.0167
62 ESSENTIAL THROMBOCYTHAEMIA 6 0.0163
63 MULTIPLE SCLEROSIS 772 0.0161
64 LEIOMYOSARCOMA 6 0.0156
65 MULTIPLE SCLEROSIS RELAPSE 1068 0.0156
66 SOLAR LENTIGO 14 0.0148
67 HUMAN PAPILLOMA VIRUS TEST POSITIVE 6 0.0147
68 PARESIS 32 0.0144
69 BAND SENSATION 18 0.0142
70 CENTRAL NERVOUS SYSTEM LESION 193 0.0140
71 CYSTOID MACULAR OEDEMA 26 0.0138
72 BLADDER DYSFUNCTION 14 0.0136
73 HYPERLIPASAEMIA 7 0.0134
74 T-LYMPHOCYTE COUNT DECREASED 9 0.0132
75 SARS-COV-2 ANTIBODY TEST NEGATIVE 6 0.0125
76 VARICELLA ZOSTER VIRUS INFECTION 24 0.0116
77 QUADRIPARESIS 19 0.0114
78 HISTOPLASMOSIS DISSEMINATED 18 0.0113
79 ACROCHORDON 15 0.0113
80 BASAL CELL CARCINOMA 171 0.0109
81 MELANOCYTIC NAEVUS 48 0.0109
82 BRAIN STEM SYNDROME 8 0.0107
83 PRIMARY BILIARY CHOLANGITIS 5 0.0106
84 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS 5 0.0103
85 LARGE FOR DATES BABY 9 0.0102
86 TRIGEMINAL NEURALGIA 41 0.0102
87 AMBLYOPIA 6 0.0102
88 VULVAL CANCER 6 0.0101
89 DRUG MONITORING PROCEDURE NOT PERFORMED 18 0.0100
90 MYELITIS 15 0.0097
91 OBSTRUCTIVE SLEEP APNOEA SYNDROME 14 0.0096
92 OPTIC NEURITIS 87 0.0096
93 REBOUND EFFECT 106 0.0094
94 MUSCLE SPASTICITY 114 0.0093
95 DISSEMINATED CRYPTOCOCCOSIS 7 0.0092
96 HAEMORRHAGIC INFARCTION 5 0.0091
97 NEUROMYELITIS OPTICA SPECTRUM DISORDER 12 0.0089
98 BRONCHIAL CARCINOMA 7 0.0089
99 CD4 LYMPHOCYTES DECREASED 19 0.0089
100 HEPATITIS E 14 0.0089
101 SINUSITIS FUNGAL 7 0.0087
102 BREAST DISCOMFORT 9 0.0087
103 CERVICAL DYSPLASIA 19 0.0087
104 ATRIOVENTRICULAR BLOCK FIRST DEGREE 36 0.0083
105 CATARACT SUBCAPSULAR 5 0.0082
106 CERVIX CARCINOMA 32 0.0082
107 HEMIPARESIS 137 0.0081
108 NEUROGENIC BLADDER 17 0.0080
109 FINE MOTOR SKILL DYSFUNCTION 23 0.0079
110 WHITE MATTER LESION 10 0.0079
111 CENTRAL NERVOUS SYSTEM INFECTION 9 0.0079
112 CONCOMITANT DISEASE AGGRAVATED 48 0.0078
113 BREAST NEOPLASM 8 0.0078
114 ENCEPHALITIS AUTOIMMUNE 10 0.0076
115 MAGNETIC RESONANCE IMAGING ABNORMAL 9 0.0075
116 HEART RATE DECREASED 264 0.0075
117 ELECTRIC SHOCK SENSATION 21 0.0075
118 TONSIL CANCER 6 0.0075
119 IMMUNE THROMBOCYTOPENIA 34 0.0074
120 PNEUMONIA CRYPTOCOCCAL 7 0.0074
121 ATAXIA 88 0.0074
122 HEAT ILLNESS 5 0.0074
123 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 6 0.0074
124 DEMYELINATION 30 0.0073
125 MICTURITION URGENCY 80 0.0070
126 LUNG ADENOCARCINOMA 21 0.0070
127 ANTIBODY TEST ABNORMAL 5 0.0069
128 PROGRESSIVE MULTIPLE SCLEROSIS 8 0.0069
129 DILATED CARDIOMYOPATHY 7 0.0069
130 NON-SMALL CELL LUNG CANCER METASTATIC 6 0.0068
131 DECREASED IMMUNE RESPONSIVENESS 67 0.0068
132 FOLLICULAR LYMPHOMA 6 0.0068
133 CORONAVIRUS TEST POSITIVE 7 0.0068
134 PERONEAL NERVE PALSY 37 0.0065
135 VERTIGO POSITIONAL 11 0.0063
136 INFECTION REACTIVATION 7 0.0061
137 POLYCYTHAEMIA VERA 5 0.0061
138 PRODUCT MEASURED POTENCY ISSUE 6 0.0060
139 SMALL CELL LUNG CANCER 9 0.0060
140 GLIOBLASTOMA MULTIFORME 5 0.0059
141 ATRIOVENTRICULAR BLOCK SECOND DEGREE 18 0.0059
142 RETINAL VEIN OCCLUSION 17 0.0059
143 INVASIVE DUCTAL BREAST CARCINOMA 15 0.0055
144 SKIN PAPILLOMA 22 0.0055
145 ELECTROCARDIOGRAM T WAVE INVERSION 12 0.0054
146 QUADRIPLEGIA 11 0.0053
147 ADENOCARCINOMA OF COLON 10 0.0053
148 B-CELL LYMPHOMA 18 0.0053
149 METASTASES TO MENINGES 12 0.0053
150 B-LYMPHOCYTE COUNT DECREASED 7 0.0051
151 NEUROENDOCRINE CARCINOMA OF THE SKIN 5 0.0051
152 LYMPHOPROLIFERATIVE DISORDER 15 0.0051
153 BICYTOPENIA 10 0.0051
154 DACTYLITIS 5 0.0051
155 URINE ABNORMALITY 23 0.0051
156 CHORIORETINOPATHY 7 0.0049
157 MONOCYTE COUNT DECREASED 6 0.0049
158 COSTOCHONDRITIS 8 0.0049
159 POST HERPETIC NEURALGIA 7 0.0049
160 OPPORTUNISTIC INFECTION 9 0.0049
161 SPINAL CORD DISORDER 8 0.0049
162 LIMB DISCOMFORT 150 0.0048
163 MALIGNANT MELANOMA IN SITU 6 0.0048
164 MUTISM 7 0.0048
165 RECTAL TENESMUS 6 0.0048
166 MALIGNANT MELANOMA 64 0.0048
167 CUTANEOUS T-CELL LYMPHOMA 6 0.0048
168 CLUMSINESS 13 0.0048
169 MICROCEPHALY 6 0.0047
170 PRODUCT SUPPLY ISSUE 33 0.0046
171 SQUAMOUS CELL CARCINOMA 43 0.0046
172 BLADDER DISORDER 45 0.0045
173 HEART DISEASE CONGENITAL 16 0.0045
174 FACIAL SPASM 5 0.0045
175 SQUAMOUS CELL CARCINOMA OF SKIN 27 0.0045
176 DYSGRAPHIA 29 0.0044
177 GAMMA-GLUTAMYLTRANSFERASE INCREASED 97 0.0044
178 OPTIC NERVE INJURY 5 0.0043
179 BALANCE DISORDER 372 0.0043
180 OPTIC ATROPHY 7 0.0043
181 PROCALCITONIN INCREASED 5 0.0043
182 FEBRILE INFECTION 5 0.0042
183 SMEAR CERVIX ABNORMAL 6 0.0042
184 SYSTEMIC INFECTION 7 0.0042
185 SENSORY LOSS 34 0.0042
186 GLIOBLASTOMA 7 0.0041
187 AUTOIMMUNE HAEMOLYTIC ANAEMIA 14 0.0041
188 IMMUNOSUPPRESSION 36 0.0041
189 AMYLOIDOSIS 7 0.0041
190 PAPILLARY THYROID CANCER 7 0.0040
191 INFREQUENT BOWEL MOVEMENTS 10 0.0040
192 TEMPERATURE INTOLERANCE 40 0.0039
193 MOVEMENT DISORDER 123 0.0038
194 CORONAVIRUS INFECTION 25 0.0038
195 DIFFUSE LARGE B-CELL LYMPHOMA 29 0.0038
196 MATERNAL EXPOSURE TIMING UNSPECIFIED 14 0.0037
197 LYMPHOCYTOSIS 8 0.0037
198 PERIODONTITIS 8 0.0037
199 MONOPLEGIA 16 0.0037
200 LIVER FUNCTION TEST INCREASED 79 0.0037
201 RETINAL OEDEMA 7 0.0037
202 BRADYARRHYTHMIA 6 0.0036
203 HYPOKINESIA 53 0.0036
204 MENINGITIS VIRAL 5 0.0036
205 HEPATIC ENZYME ABNORMAL 18 0.0036
206 PIGMENTATION DISORDER 22 0.0036
207 GAZE PALSY 6 0.0035
208 DYSARTHRIA 131 0.0035
209 NEUROLOGICAL DECOMPENSATION 8 0.0035
210 FLAT AFFECT 8 0.0035
211 SPINAL CORD INJURY 6 0.0034
212 PRECANCEROUS SKIN LESION 5 0.0034
213 NOCTURIA 41 0.0034
214 LYMPHOCYTE COUNT INCREASED 11 0.0034
215 URINARY HESITATION 8 0.0033
216 WALKING DISABILITY 7 0.0033
217 MOBILITY DECREASED 240 0.0033
218 SARS-COV-2 TEST POSITIVE 44 0.0033
219 GAIT DISTURBANCE 637 0.0033
220 NORMAL NEWBORN 18 0.0033
221 INCONTINENCE 35 0.0033
222 COVID-19 PNEUMONIA 39 0.0033
223 PROCTITIS 9 0.0032
224 BLOOD CREATININE DECREASED 10 0.0032
225 HUMAN HERPESVIRUS 6 INFECTION 6 0.0032
226 COORDINATION ABNORMAL 44 0.0032
227 IMMUNODEFICIENCY 47 0.0031
228 NEUROLOGICAL SYMPTOM 18 0.0031
229 BREAST MASS 21 0.0031
230 ADENOCARCINOMA 7 0.0031
231 WHITE BLOOD CELL COUNT DECREASED 338 0.0031
232 HEPATOSPLENOMEGALY 8 0.0031
233 SKIN CANCER 67 0.0031
234 PARALYSIS 44 0.0031
235 URINE ODOUR ABNORMAL 18 0.0031
236 LUNG NEOPLASM 13 0.0030
237 COVID-19 534 0.0030
238 MOTOR DYSFUNCTION 31 0.0030
239 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 6 0.0030
240 UROSEPSIS 28 0.0030
241 CEREBRAL ATROPHY 12 0.0030
242 AREFLEXIA 8 0.0030
243 COGNITIVE DISORDER 139 0.0030
244 APHASIA 89 0.0029
245 GAIT INABILITY 98 0.0029
246 LAZINESS 5 0.0029
247 ENCEPHALITIS 20 0.0029
248 HYPOAESTHESIA 431 0.0029
249 BLOOD IMMUNOGLOBULIN G DECREASED 7 0.0028
250 LANGUAGE DISORDER 6 0.0028
251 SKIN LESION 76 0.0028
252 LEUKOPENIA 138 0.0028
253 CEREBELLAR SYNDROME 6 0.0027
254 HEPATIC ENZYME INCREASED 186 0.0027
255 URINARY TRACT INFECTION 461 0.0027
256 MUSCULAR WEAKNESS 307 0.0027
257 ACTINIC KERATOSIS 7 0.0027
258 SENSORY DISTURBANCE 43 0.0027
259 THROAT CLEARING 10 0.0027
260 VISUAL IMPAIRMENT 330 0.0027
261 DIPLOPIA 69 0.0027
262 VISUAL FIELD DEFECT 19 0.0026
263 OCULAR DISCOMFORT 29 0.0026
264 FACIAL PARALYSIS 22 0.0026
265 CEREBRAL DISORDER 19 0.0026
266 PHOTOPSIA 16 0.0025
267 DIPLEGIA 5 0.0025
268 VARICELLA 6 0.0025
269 NON-SMALL CELL LUNG CANCER 12 0.0025
270 MEMORY IMPAIRMENT 342 0.0025
271 STATUS EPILEPTICUS 28 0.0025
272 ANAL INCONTINENCE 22 0.0024
273 VENTRICULAR SEPTAL DEFECT 14 0.0024
274 PARAPLEGIA 7 0.0024
275 SUSPECTED COVID-19 8 0.0024
276 BRADYCARDIA 128 0.0024
277 URINARY TRACT INFECTION BACTERIAL 6 0.0024
278 EYE CONTUSION 5 0.0024
279 MATERNAL EXPOSURE BEFORE PREGNANCY 16 0.0023
280 CARDIAC FLUTTER 15 0.0023
281 HYPERREFLEXIA 8 0.0023
282 INFECTION SUSCEPTIBILITY INCREASED 5 0.0023
283 IMMUNE SYSTEM DISORDER 30 0.0023
284 ENDOMETRIAL CANCER 5 0.0023
285 CLOSTRIDIUM TEST POSITIVE 5 0.0023
286 URINARY INCONTINENCE 67 0.0023
287 FACIAL PARESIS 8 0.0023
288 NYSTAGMUS 12 0.0023
289 MACULOPATHY 8 0.0023
290 TALIPES 7 0.0023
291 VITREOUS FLOATERS 22 0.0022
292 BRAIN FOG 35 0.0022
293 CLONUS 6 0.0022
294 PYELONEPHRITIS 19 0.0022
295 LYMPHOEDEMA 15 0.0022
296 LOWER RESPIRATORY TRACT INFECTION 98 0.0022
297 MUSCULOSKELETAL DISCOMFORT 37 0.0021
298 LIGAMENT SPRAIN 21 0.0021
299 SKIN ABRASION 10 0.0021
300 POLLAKIURIA 88 0.0021
301 CYSTITIS 67 0.0021
302 NEURALGIA 51 0.0021
303 VISION BLURRED 287 0.0021
304 DECUBITUS ULCER 17 0.0021
305 BLOOD TEST ABNORMAL 29 0.0021
306 DYSSTASIA 60 0.0021
307 AUTONOMIC NERVOUS SYSTEM IMBALANCE 6 0.0021
308 PERSONALITY CHANGE 19 0.0020
309 STRABISMUS 6 0.0020
310 MUSCLE TIGHTNESS 33 0.0020
311 HERPES ZOSTER 116 0.0020
312 FACIAL PAIN 18 0.0020
313 BRAIN HERNIATION 6 0.0020
314 INCOHERENT 13 0.0020
315 URINE ANALYSIS ABNORMAL 6 0.0020
316 EXTRASYSTOLES 14 0.0020
317 ANKLE FRACTURE 31 0.0020
318 MYELOFIBROSIS 6 0.0020
319 HEAD DISCOMFORT 35 0.0020
320 DRUG EFFECT LESS THAN EXPECTED 29 0.0020
321 SPEECH DISORDER 102 0.0019
322 HEMIPLEGIA 16 0.0019
323 PARTIAL SEIZURES 10 0.0019
324 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
325 ABDOMINAL MASS 5 0.0019
326 GUILLAIN-BARRE SYNDROME 9 0.0019
327 LOSS OF CONTROL OF LEGS 7 0.0018
328 PRODUCT DISTRIBUTION ISSUE 17 0.0018
329 HYPOGAMMAGLOBULINAEMIA 12 0.0018
330 DEAFNESS NEUROSENSORY 6 0.0018
331 FALL 607 0.0018
332 GRIP STRENGTH DECREASED 16 0.0018
333 ALANINE AMINOTRANSFERASE INCREASED 111 0.0018
334 PRODUCT DOSE OMISSION ISSUE 524 0.0018
335 PRODUCT AVAILABILITY ISSUE 40 0.0018
336 HYPERTENSION 372 0.0018
337 EYE MOVEMENT DISORDER 12 0.0018
338 LYMPHOMA 27 0.0017
339 HYPERTONIA 10 0.0017
340 INTRACRANIAL ANEURYSM 7 0.0017
341 URINARY RETENTION 58 0.0017
342 FUNCTIONAL GASTROINTESTINAL DISORDER 6 0.0017
343 BILIARY COLIC 5 0.0017
344 HEADACHE 1073 0.0017
345 MIGRAINE 163 0.0017
346 FEELING OF BODY TEMPERATURE CHANGE 10 0.0017
347 RETINAL HAEMORRHAGE 12 0.0017
348 PERIPHERAL SWELLING 257 0.0017
349 PARAESTHESIA 262 0.0017
350 DISEASE RECURRENCE 79 0.0017
351 MUSCLE FATIGUE 7 0.0017
352 MONOCYTE COUNT INCREASED 6 0.0017
353 SPONDYLITIS 6 0.0016
354 VERTIGO 100 0.0016
355 VITAMIN D DEFICIENCY 16 0.0016
356 THROMBOCYTOSIS 6 0.0016
357 DIZZINESS 816 0.0016
358 EYE PAIN 92 0.0016
359 MUSCULOSKELETAL DISORDER 31 0.0016
360 ECTOPIC PREGNANCY 5 0.0016
361 LOWER LIMB FRACTURE 31 0.0016
362 EYE DISORDER 53 0.0016
363 FATIGUE 1248 0.0016
364 AUTOIMMUNE THYROIDITIS 6 0.0016
365 BLOOD PRESSURE ABNORMAL 31 0.0016
366 SINUS BRADYCARDIA 15 0.0016
367 DIZZINESS POSTURAL 15 0.0015
368 SKIN NECROSIS 8 0.0015
369 SEIZURE 177 0.0015
370 MUSCULOSKELETAL STIFFNESS 134 0.0015
371 BUNDLE BRANCH BLOCK RIGHT 7 0.0015
372 ENERGY INCREASED 9 0.0015
373 BRAIN NEOPLASM 14 0.0015
374 CATATONIA 8 0.0015
375 DYSURIA 56 0.0015
376 OVARIAN CANCER 14 0.0015
377 NEAR DEATH EXPERIENCE 5 0.0015
378 TIBIA FRACTURE 7 0.0015
379 GINGIVITIS 8 0.0015
380 PRODUCT DOSE OMISSION IN ERROR 42 0.0015
381 NEOPLASM RECURRENCE 5 0.0015
382 HEPATIC CYST 5 0.0015
383 EPILEPSY 44 0.0014
384 GASTROINTESTINAL CARCINOMA 13 0.0014
385 EYE HAEMORRHAGE 19 0.0014
386 TRANSIENT ISCHAEMIC ATTACK 48 0.0014
387 MUSCLE CONTRACTIONS INVOLUNTARY 5 0.0014
388 DEPRESSIVE SYMPTOM 5 0.0014
389 PERIORBITAL SWELLING 8 0.0014
390 TONGUE DISCOMFORT 6 0.0014
391 POOR PERIPHERAL CIRCULATION 6 0.0014
392 ABSCESS LIMB 6 0.0014
393 HEPATIC PAIN 6 0.0014
394 PRODUCT DISPENSING ISSUE 6 0.0014
395 ABNORMAL SENSATION IN EYE 6 0.0014
396 TREMOR 230 0.0014
397 FEELING ABNORMAL 330 0.0014
398 FOOT FRACTURE 26 0.0014
399 DYSPHEMIA 6 0.0014
400 ENDOCARDITIS 7 0.0014
401 ERECTILE DYSFUNCTION 35 0.0014
402 BRADYKINESIA 8 0.0014
403 RESPIRATORY RATE INCREASED 12 0.0014
404 BREAST CANCER 125 0.0013
405 CHRONIC SINUSITIS 5 0.0013
406 PAPILLOEDEMA 6 0.0013
407 HEAD INJURY 42 0.0013
408 KIDNEY INFECTION 26 0.0013
409 OVERWEIGHT 7 0.0013
410 BLOOD PRESSURE INCREASED 199 0.0013
411 ILLNESS 134 0.0013
412 APHTHOUS ULCER 10 0.0013
413 VASCULITIS 15 0.0013
414 CHROMATURIA 29 0.0013
415 HEART RATE IRREGULAR 29 0.0013
416 ORAL HERPES 25 0.0013
417 NEUTROPHIL COUNT INCREASED 13 0.0013
418 INTRACRANIAL PRESSURE INCREASED 7 0.0013
419 WHITE BLOOD CELL COUNT ABNORMAL 8 0.0013
420 PURPURA 11 0.0012
421 FUNGAL SKIN INFECTION 5 0.0012
422 FRUSTRATION TOLERANCE DECREASED 10 0.0012
423 CONFUSIONAL STATE 199 0.0012
424 AMNESIA 80 0.0012
425 HAEMATURIA 42 0.0012
426 PHOTOPHOBIA 23 0.0012
427 STAPHYLOCOCCAL SEPSIS 6 0.0012
428 FEELING JITTERY 23 0.0012
429 ASTHENIA 453 0.0012
430 HYPOAESTHESIA ORAL 18 0.0012
431 NERVE COMPRESSION 11 0.0012
432 DRUG TOLERANCE 6 0.0012
433 PATHOLOGICAL FRACTURE 6 0.0012
434 VITAMIN D DECREASED 10 0.0012
435 LIVER FUNCTION TEST ABNORMAL 34 0.0012
436 HYPERTENSIVE CRISIS 13 0.0012
437 PRODUCT TEMPERATURE EXCURSION ISSUE 6 0.0012
438 CEREBRAL ISCHAEMIA 6 0.0012
439 CONTUSION 112 0.0012
440 HEPATITIS B 7 0.0012
441 HYPERBILIRUBINAEMIA 12 0.0012
442 ASPARTATE AMINOTRANSFERASE INCREASED 61 0.0011
443 ONYCHOMYCOSIS 5 0.0011
444 JOINT DISLOCATION 12 0.0011
445 CYTOMEGALOVIRUS INFECTION REACTIVATION 5 0.0011
446 PALPITATIONS 132 0.0011
447 JOINT INJURY 24 0.0011
448 PRODUCT DOSE OMISSION 73 0.0011
449 DEPRESSED MOOD 59 0.0011
450 BLEPHAROSPASM 7 0.0011
451 PANIC REACTION 8 0.0011
452 LIVER DISORDER 49 0.0011
453 SOMNOLENCE 222 0.0011
454 MUSCULOSKELETAL CHEST PAIN 17 0.0011
455 NONSPECIFIC REACTION 6 0.0011
456 CHOLECYSTITIS 13 0.0011
457 ACCIDENT 13 0.0011
458 PROSTATIC DISORDER 6 0.0011
459 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
460 BLOOD PRESSURE FLUCTUATION 26 0.0011
461 UPPER RESPIRATORY TRACT INFECTION 50 0.0011
462 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
463 LOCALISED OEDEMA 5 0.0011
464 SLUGGISHNESS 11 0.0011
465 HERPES SIMPLEX 7 0.0011
466 BLOOD PRESSURE SYSTOLIC INCREASED 21 0.0011
467 HEART RATE ABNORMAL 6 0.0011
468 DISTURBANCE IN ATTENTION 58 0.0011
469 ATRIAL SEPTAL DEFECT 9 0.0011
470 DIARRHOEA HAEMORRHAGIC 10 0.0011
471 RIB FRACTURE 22 0.0011
472 ORAL CANDIDIASIS 14 0.0011
473 PAIN IN EXTREMITY 313 0.0011
474 GLOMERULAR FILTRATION RATE DECREASED 13 0.0011
475 SPUTUM DISCOLOURED 10 0.0011
476 PETECHIAE 11 0.0011
477 OSTEOMYELITIS 19 0.0010
478 EYE INFLAMMATION 10 0.0010
479 ATRIOVENTRICULAR BLOCK COMPLETE 7 0.0010
480 HERPES VIRUS INFECTION 6 0.0010
481 GLAUCOMA 20 0.0010
482 EXTRA DOSE ADMINISTERED 42 0.0010
483 NASOPHARYNGITIS 190 0.0010
484 BLINDNESS 42 0.0010
485 CHOKING 20 0.0010
486 DISEASE PROGRESSION 121 0.0010
487 ELECTROCARDIOGRAM ABNORMAL 8 0.0010
488 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
489 INFECTION 147 0.0010
490 PRODUCT DISPENSING ERROR 22 0.0010
491 LOW BIRTH WEIGHT BABY 8 0.0010
492 FEELING COLD 28 0.0010
493 ODYNOPHAGIA 6 0.0010
494 ABDOMINAL DISCOMFORT 168 0.0010
495 THERAPY NON-RESPONDER 45 0.0010
496 ELECTROCARDIOGRAM QT PROLONGED 36 0.0010
497 PNEUMONIA ASPIRATION 25 0.0010
498 PAPULE 7 0.0010
499 THERMAL BURN 7 0.0010
500 ANGINA PECTORIS 28 0.0010
501 GENERAL PHYSICAL HEALTH DETERIORATION 113 0.0010
502 EYE INFECTION 11 0.0010
503 NEOPLASM MALIGNANT 65 0.0010
504 DRUG INTOLERANCE 94 0.0010
505 PARAESTHESIA ORAL 14 0.0010
506 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
507 OLIGURIA 6 0.0010
508 SCAB 11 0.0010
509 APPENDICITIS 9 0.0010
510 INTERVERTEBRAL DISC PROTRUSION 21 0.0010
511 LYMPHADENOPATHY 34 0.0010
512 FLANK PAIN 9 0.0010
513 LIMB INJURY 26 0.0010
514 PRESCRIBED UNDERDOSE 19 0.0010
515 BLOOD PRESSURE DIASTOLIC DECREASED 7 0.0009
516 PERIPHERAL COLDNESS 13 0.0009
517 FULL BLOOD COUNT ABNORMAL 10 0.0009
518 PULMONARY MASS 14 0.0009
519 MUSCLE SPASMS 172 0.0009
520 COMPRESSION FRACTURE 5 0.0009
521 CELLULITIS 47 0.0009
522 APHONIA 13 0.0009
523 SKIN HYPERPIGMENTATION 8 0.0009
524 PRODUCT SIZE ISSUE 5 0.0009
525 ANAL ABSCESS 5 0.0009
526 BLINDNESS UNILATERAL 13 0.0009
527 ASPERGILLUS INFECTION 6 0.0009
528 BOWEL MOVEMENT IRREGULARITY 7 0.0009
529 NECK PAIN 51 0.0009
530 THINKING ABNORMAL 17 0.0009
531 DEAFNESS UNILATERAL 5 0.0009
532 ATRIOVENTRICULAR BLOCK 7 0.0009
533 CONDITION AGGRAVATED 275 0.0009
534 CONCUSSION 7 0.0009
535 EXPOSURE DURING PREGNANCY 56 0.0009
536 BACK PAIN 209 0.0009
537 SKIN MASS 6 0.0009
538 MENINGITIS 6 0.0009
539 HEPATOTOXICITY 20 0.0009
540 GASTROINTESTINAL INFECTION 8 0.0009
541 TORSADE DE POINTES 7 0.0009
542 WRONG PRODUCT ADMINISTERED 6 0.0009
543 INFLUENZA LIKE ILLNESS 73 0.0009
544 MALAISE 388 0.0009
545 CHOLECYSTITIS ACUTE 5 0.0009
546 PRODUCT PRESCRIBING ERROR 21 0.0009
547 RENAL CYST 7 0.0009
548 TREATMENT FAILURE 73 0.0009
549 CHEST DISCOMFORT 90 0.0009
550 SCIATICA 14 0.0009
551 COLON CANCER 13 0.0009
552 PNEUMONIA BACTERIAL 8 0.0009
553 RETINAL DETACHMENT 8 0.0009
554 MUSCLE ATROPHY 11 0.0009
555 RHINITIS 7 0.0009
556 MUSCLE TWITCHING 20 0.0009
557 OEDEMA PERIPHERAL 104 0.0009
558 ESCHERICHIA INFECTION 7 0.0009
559 PANIC ATTACK 31 0.0008
560 ACUTE MYOCARDIAL INFARCTION 25 0.0008
561 LABORATORY TEST ABNORMAL 25 0.0008
562 MACULAR DEGENERATION 10 0.0008
563 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
564 NERVOUS SYSTEM DISORDER 26 0.0008
565 THYROID CANCER 10 0.0008
566 ABDOMINAL PAIN LOWER 21 0.0008
567 MYELODYSPLASTIC SYNDROME 12 0.0008
568 ADVERSE REACTION 11 0.0008
569 FOETAL EXPOSURE DURING PREGNANCY 67 0.0008
570 BLINDNESS TRANSIENT 6 0.0008
571 MENISCUS INJURY 5 0.0008
572 VISUAL ACUITY REDUCED 27 0.0008
573 MUSCLE STRAIN 7 0.0008
574 DISORIENTATION 32 0.0008
575 INFLUENZA 90 0.0008
576 PYREXIA 279 0.0008
577 CATARACT 48 0.0008
578 UPPER LIMB FRACTURE 16 0.0008
579 HYPOTONIA 8 0.0008
580 LETHARGY 46 0.0008
581 CHEST PAIN 148 0.0008
582 PRODUCT SUBSTITUTION ISSUE 46 0.0008
583 BRAIN INJURY 8 0.0008
584 MITRAL VALVE INCOMPETENCE 9 0.0008
585 BLOOD CHOLESTEROL INCREASED 37 0.0008
586 CHILLS 93 0.0008
587 IMPAIRED HEALING 26 0.0008
588 TOOTH ABSCESS 8 0.0008
589 THERAPY INTERRUPTED 56 0.0008
590 ARRHYTHMIA 37 0.0008
591 EUPHORIC MOOD 8 0.0008
592 FUNGAL INFECTION 26 0.0008
593 OROPHARYNGEAL PAIN 72 0.0008
594 HIP FRACTURE 25 0.0008
595 GASTROENTERITIS VIRAL 14 0.0008
596 METASTASES TO CENTRAL NERVOUS SYSTEM 10 0.0008
597 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
598 OROPHARYNGEAL DISCOMFORT 7 0.0008
599 RESTLESS LEGS SYNDROME 14 0.0008
600 SPINAL PAIN 9 0.0008
601 RESPIRATORY TRACT INFECTION 20 0.0008
602 HYPERSOMNIA 22 0.0008
603 GASTROINTESTINAL DISORDER 68 0.0008
604 BURNING SENSATION 53 0.0008
605 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
606 JOINT SWELLING 91 0.0008
607 GASTROENTERITIS 11 0.0008
608 PREMATURE DELIVERY 12 0.0008
609 HEPATIC STEATOSIS 14 0.0008
610 WRIST FRACTURE 9 0.0008
611 BREAST PAIN 8 0.0007
612 DYSPHAGIA 71 0.0007
613 HEPATITIS C 9 0.0007
614 FULL BLOOD COUNT DECREASED 15 0.0007
615 HOT FLUSH 56 0.0007
616 TYPE 2 DIABETES MELLITUS 25 0.0007
617 MUSCLE DISORDER 6 0.0007
618 METASTASES TO LYMPH NODES 5 0.0007
619 THERAPY CESSATION 38 0.0007
620 SPINAL DISORDER 7 0.0007
621 SKIN LACERATION 8 0.0007
622 BACK INJURY 8 0.0007
623 DRUG-INDUCED LIVER INJURY 23 0.0007
624 ENCEPHALOPATHY 18 0.0007
625 POLYURIA 6 0.0007
626 CEREBROVASCULAR ACCIDENT 124 0.0007
627 INFARCTION 5 0.0007
628 ISCHAEMIC STROKE 13 0.0007
629 NERVOUSNESS 38 0.0007
630 HEART RATE INCREASED 72 0.0007
631 MENSTRUAL DISORDER 6 0.0007
632 BLOOD PRESSURE DECREASED 48 0.0007
633 VIRAL INFECTION 24 0.0007
634 EAR PAIN 14 0.0007
635 MATERNAL EXPOSURE DURING PREGNANCY 64 0.0007
636 WOUND 20 0.0007
637 MASS 10 0.0007
638 BRAIN OEDEMA 9 0.0007
639 CARDIOVASCULAR DISORDER 18 0.0007
640 ILL-DEFINED DISORDER 43 0.0007
641 SEASONAL ALLERGY 10 0.0007
642 HAND FRACTURE 5 0.0007
643 PAIN 433 0.0007
644 LOCALISED INFECTION 17 0.0007
645 MENTAL IMPAIRMENT 17 0.0007
646 METASTASIS 5 0.0007
647 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 126 0.0007
648 NEPHROLITHIASIS 32 0.0007
649 PRODUCT STORAGE ERROR 61 0.0007
650 HYPERTHYROIDISM 10 0.0007
651 ALOPECIA 135 0.0007
652 URINE OUTPUT DECREASED 6 0.0007
653 COUGH 192 0.0007
654 SPINAL OSTEOARTHRITIS 6 0.0007
655 SEPSIS 76 0.0007
656 COLD SWEAT 12 0.0007
657 INSOMNIA 181 0.0007
658 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
659 PSYCHIATRIC SYMPTOM 5 0.0007
660 BLOOD IRON DECREASED 8 0.0007
661 CHOLELITHIASIS 22 0.0007
662 HAEMOLYTIC ANAEMIA 6 0.0007
663 MUSCLE RIGIDITY 8 0.0007
664 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
665 UVEITIS 9 0.0007
666 NAUSEA 520 0.0007
667 SINUSITIS 67 0.0007
668 FEELING HOT 40 0.0007
669 ABORTION SPONTANEOUS 26 0.0006
670 SPINAL FRACTURE 13 0.0006
671 THYROID DISORDER 10 0.0006
672 CONJUNCTIVITIS 12 0.0006
673 GASTRITIS 17 0.0006
674 EYE SWELLING 24 0.0006
675 CYST 8 0.0006
676 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
677 MENTAL DISORDER 28 0.0006
678 PELVIC FRACTURE 5 0.0006
679 DRY MOUTH 52 0.0006
680 INFLAMMATION 33 0.0006
681 SECRETION DISCHARGE 8 0.0006
682 BODY TEMPERATURE INCREASED 13 0.0006
683 ATRIAL FIBRILLATION 62 0.0006
684 ANXIETY 181 0.0006
685 TOOTH FRACTURE 7 0.0006
686 RHINORRHOEA 41 0.0006
687 DEPRESSION 144 0.0006
688 FURUNCLE 5 0.0006
689 TRANSAMINASES INCREASED 14 0.0006
690 AMENORRHOEA 11 0.0006
691 SKIN INFECTION 7 0.0006
692 ANOSMIA 9 0.0006
693 APATHY 9 0.0006
694 DYSKINESIA 25 0.0006
695 PHARYNGEAL SWELLING 6 0.0006
696 EMBOLISM 5 0.0006
697 AGEUSIA 15 0.0006
698 INTENTIONAL DOSE OMISSION 17 0.0006
699 PRODUCT USE IN UNAPPROVED INDICATION 147 0.0006
700 BLOOD BILIRUBIN INCREASED 16 0.0006
701 ADVERSE DRUG REACTION 53 0.0006
702 EJECTION FRACTION DECREASED 9 0.0006
703 HAEMATOMA 15 0.0006
704 VENTRICULAR EXTRASYSTOLES 6 0.0006
705 RASH MACULAR 20 0.0006
706 NAIL DISORDER 5 0.0006
707 HALLUCINATION, AUDITORY 9 0.0006
708 SWELLING 53 0.0006
709 SKIN DISCOLOURATION 26 0.0006
710 PAIN IN JAW 16 0.0006
711 HYPOTHYROIDISM 18 0.0006
712 DYSPNOEA 319 0.0006
713 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 40 0.0006
714 HYPERSENSITIVITY 104 0.0006
715 LUNG NEOPLASM MALIGNANT 23 0.0006
716 BACK DISORDER 9 0.0006
717 LEUKOCYTOSIS 10 0.0006
718 HEPATITIS 14 0.0005
719 DYSPHONIA 32 0.0005
720 TINNITUS 25 0.0005
721 PLATELET COUNT INCREASED 7 0.0005
722 CONSTIPATION 117 0.0005
723 WEIGHT INCREASED 120 0.0005
724 OEDEMA 29 0.0005
725 PRESYNCOPE 13 0.0005
726 LOSS OF CONSCIOUSNESS 68 0.0005
727 MYOCARDIAL INFARCTION 92 0.0005
728 PRODUCT PACKAGING ISSUE 5 0.0005
729 EAR INFECTION 14 0.0005
730 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
731 NIGHTMARE 18 0.0005
732 AFFECT LABILITY 5 0.0005
733 HALLUCINATION 39 0.0005
734 DRUG INEFFECTIVE 681 0.0005
735 NEUTROPHIL COUNT DECREASED 21 0.0005
736 DELUSION 8 0.0005
737 MOOD ALTERED 14 0.0005
738 HYPOACUSIS 22 0.0005
739 NASAL CONGESTION 30 0.0005
740 ASCITES 15 0.0005
741 SYNCOPE 51 0.0005
742 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
743 THIRST 9 0.0005
744 UNRESPONSIVE TO STIMULI 13 0.0005
745 HUNGER 7 0.0005
746 CARDIAC DISORDER 47 0.0005
747 DRY EYE 25 0.0005
748 WITHDRAWAL SYNDROME 21 0.0005
749 CARPAL TUNNEL SYNDROME 7 0.0005
750 TOOTHACHE 9 0.0005
751 SKIN REACTION 7 0.0005
752 HYPOTENSION 99 0.0005
753 DRY THROAT 5 0.0005
754 SNEEZING 11 0.0005
755 RED BLOOD CELL COUNT DECREASED 14 0.0005
756 METASTASES TO BONE 8 0.0005
757 INITIAL INSOMNIA 5 0.0005
758 PHOTOSENSITIVITY REACTION 8 0.0005
759 PHARYNGITIS 6 0.0005
760 JAUNDICE 13 0.0005
761 HEPATIC FUNCTION ABNORMAL 18 0.0005
762 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
763 CYTOMEGALOVIRUS INFECTION 8 0.0005
764 HYPERHIDROSIS 62 0.0005
765 EYE DISCHARGE 5 0.0005
766 BLOOD SODIUM DECREASED 9 0.0005
767 PNEUMONITIS 13 0.0005
768 SWELLING FACE 31 0.0005
769 FRACTURE 9 0.0005
770 DISCOMFORT 29 0.0005
771 CEREBRAL HAEMORRHAGE 17 0.0005
772 VOMITING 223 0.0005
773 BLOOD URINE PRESENT 9 0.0005
774 PSYCHOTIC DISORDER 14 0.0005
775 CANDIDA INFECTION 8 0.0005
776 RENAL PAIN 5 0.0005
777 DYSPEPSIA 46 0.0005
778 ABDOMINAL PAIN UPPER 96 0.0005
779 PREMATURE BABY 14 0.0005
780 DECREASED APPETITE 108 0.0005
781 ACCIDENTAL OVERDOSE 17 0.0005
782 PNEUMONIA 150 0.0005
783 MENSTRUATION DELAYED 5 0.0005
784 HAND DEFORMITY 6 0.0005
785 ROAD TRAFFIC ACCIDENT 19 0.0005
786 HAEMATOCRIT DECREASED 9 0.0005
787 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
788 FOOT DEFORMITY 5 0.0005
789 CEREBRAL INFARCTION 11 0.0004
790 NERVE INJURY 5 0.0004
791 LIVER INJURY 11 0.0004
792 QUALITY OF LIFE DECREASED 6 0.0004
793 PRODUCTIVE COUGH 21 0.0004
794 RESPIRATORY FAILURE 32 0.0004
795 ABSCESS 7 0.0004
796 ABDOMINAL PAIN 102 0.0004
797 INTERNAL HAEMORRHAGE 5 0.0004
798 ORAL DISCOMFORT 6 0.0004
799 RENAL DISORDER 20 0.0004
800 BACTERIAL INFECTION 8 0.0004
801 MANIA 7 0.0004
802 EATING DISORDER 9 0.0004
803 IMPAIRED WORK ABILITY 9 0.0004
804 PULMONARY EMBOLISM 40 0.0004
805 DEAFNESS 11 0.0004
806 ECZEMA 22 0.0004
807 SKIN DISORDER 14 0.0004
808 HYPERLIPIDAEMIA 5 0.0004
809 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
810 DIARRHOEA 268 0.0004
811 FLUID RETENTION 21 0.0004
812 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
813 SLEEP DISORDER 29 0.0004
814 ARTHRALGIA 170 0.0004
815 PAIN OF SKIN 11 0.0004
816 WEIGHT DECREASED 112 0.0004
817 THROAT IRRITATION 18 0.0004
818 INTENTIONAL PRODUCT USE ISSUE 35 0.0004
819 NEUTROPENIA 54 0.0004
820 CONTRAINDICATED PRODUCT ADMINISTERED 12 0.0004
821 MENTAL STATUS CHANGES 11 0.0004
822 TACHYCARDIA 35 0.0004
823 INTRAOCULAR PRESSURE INCREASED 5 0.0004
824 EMOTIONAL DISORDER 12 0.0004
825 PRODUCT USE ISSUE 73 0.0004
826 C-REACTIVE PROTEIN INCREASED 14 0.0004
827 AGITATION 28 0.0004
828 JOINT STIFFNESS 10 0.0004
829 PNEUMOTHORAX 6 0.0004
830 BREAST CANCER FEMALE 10 0.0004
831 IRRITABLE BOWEL SYNDROME 8 0.0004
832 INCORRECT DOSE ADMINISTERED 85 0.0004
833 POOR QUALITY SLEEP 8 0.0004
834 BLOOD POTASSIUM INCREASED 6 0.0004
835 DEEP VEIN THROMBOSIS 24 0.0004
836 FAECES DISCOLOURED 8 0.0004
837 IMPAIRED GASTRIC EMPTYING 5 0.0004
838 INCREASED APPETITE 7 0.0004
839 CORONARY ARTERY OCCLUSION 5 0.0004
840 FLUSHING 37 0.0004
841 MUSCULOSKELETAL PAIN 19 0.0004
842 DIVERTICULITIS 10 0.0004
843 BLOOD UREA INCREASED 6 0.0004
844 ORAL PAIN 8 0.0004
845 RASH 154 0.0004
846 MYALGIA 60 0.0004
847 CIRCULATORY COLLAPSE 6 0.0004
848 BRONCHITIS 26 0.0004
849 ERYTHEMA 72 0.0003
850 PRODUCT PHYSICAL ISSUE 7 0.0003
851 NEUROPATHY PERIPHERAL 33 0.0003
852 PANCREATIC CARCINOMA 10 0.0003
853 DELIRIUM 12 0.0003
854 TASTE DISORDER 7 0.0003
855 METASTASES TO LIVER 6 0.0003
856 PANCREATITIS 18 0.0003
857 PANCYTOPENIA 19 0.0003
858 THROMBOSIS 27 0.0003
859 GASTROOESOPHAGEAL REFLUX DISEASE 27 0.0003
860 FEAR 9 0.0003
861 HALLUCINATION, VISUAL 7 0.0003
862 LACRIMATION INCREASED 10 0.0003
863 ABNORMAL DREAMS 9 0.0003
864 ANGER 11 0.0003
865 FEMUR FRACTURE 10 0.0003
866 DEMENTIA 9 0.0003
867 BLISTER 18 0.0003
868 INTESTINAL OBSTRUCTION 12 0.0003
869 ABDOMINAL DISTENSION 33 0.0003
870 DIABETES MELLITUS 24 0.0003
871 SLEEP APNOEA SYNDROME 6 0.0003
872 RASH ERYTHEMATOUS 15 0.0003
873 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
874 SKIN ULCER 8 0.0003
875 OSTEOARTHRITIS 13 0.0003
876 MEDICATION ERROR 17 0.0003
877 MENORRHAGIA 6 0.0003
878 ARTHRITIS 24 0.0003
879 OSTEONECROSIS 10 0.0003
880 DISABILITY 6 0.0003
881 SINUS DISORDER 6 0.0003
882 CRYING 11 0.0003
883 OXYGEN SATURATION DECREASED 17 0.0003
884 PRURITUS 115 0.0003
885 DYSPNOEA EXERTIONAL 11 0.0003
886 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
887 FIBROMYALGIA 7 0.0003
888 ARTHROPATHY 16 0.0003
889 ORTHOSTATIC HYPOTENSION 5 0.0003
890 EOSINOPHILIA 5 0.0003
891 DRUG INTERACTION 45 0.0003
892 MOOD SWINGS 9 0.0003
893 HYPOKALAEMIA 13 0.0003
894 OFF LABEL USE 246 0.0003
895 RESTLESSNESS 10 0.0003
896 TOOTH DISORDER 6 0.0003
897 RESPIRATORY DISORDER 8 0.0003
898 COLITIS 10 0.0003
899 PLEURAL EFFUSION 16 0.0003
900 URTICARIA 44 0.0003
901 CHOLESTASIS 5 0.0003
902 HERNIA 5 0.0003
903 ERUCTATION 5 0.0003
904 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 52 0.0003
905 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0003
906 ABNORMAL BEHAVIOUR 10 0.0003
907 PROCEDURAL PAIN 7 0.0003
908 DRUG WITHDRAWAL SYNDROME 22 0.0003
909 OSTEOPOROSIS 10 0.0002
910 EPISTAXIS 18 0.0002
911 LIP SWELLING 8 0.0002
912 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
913 DERMATITIS 5 0.0002
914 EYE PRURITUS 8 0.0002
915 RENAL IMPAIRMENT 20 0.0002
916 BLADDER CANCER 14 0.0002
917 MOUTH ULCERATION 5 0.0002
918 GASTRIC CANCER 6 0.0002
919 GASTRIC DISORDER 8 0.0002
920 BLOOD POTASSIUM DECREASED 7 0.0002
921 COMA 11 0.0002
922 HYPONATRAEMIA 13 0.0002
923 DYSGEUSIA 17 0.0002
924 HYPERKALAEMIA 8 0.0002
925 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
926 DRY SKIN 30 0.0002
927 CARDIAC FAILURE 18 0.0002
928 ACNE 17 0.0002
929 RASH PAPULAR 5 0.0002
930 INJECTION SITE REACTION 15 0.0002
931 INTENTIONAL PRODUCT MISUSE 19 0.0002
932 IRRITABILITY 13 0.0002
933 DEATH 185 0.0002
934 SUICIDE ATTEMPT 13 0.0002
935 CARDIAC ARREST 17 0.0002
936 BONE PAIN 12 0.0002
937 TREATMENT NONCOMPLIANCE 11 0.0002
938 PULMONARY OEDEMA 9 0.0002
939 HYPOXIA 7 0.0002
940 THERAPEUTIC RESPONSE DECREASED 12 0.0002
941 HAEMATEMESIS 5 0.0002
942 ADVERSE EVENT 18 0.0002
943 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
944 SUICIDAL IDEATION 17 0.0002
945 SEPTIC SHOCK 8 0.0002
946 STAPHYLOCOCCAL INFECTION 6 0.0002
947 SKIN BURNING SENSATION 13 0.0002
948 STOMATITIS 11 0.0002
949 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
950 THROMBOCYTOPENIA 20 0.0002
951 ANAEMIA 34 0.0002
952 PLATELET COUNT DECREASED 19 0.0002
953 PSORIASIS 23 0.0002
954 RENAL FAILURE 23 0.0002
955 DEHYDRATION 23 0.0002
956 UNEVALUABLE EVENT 13 0.0002
957 OCULAR HYPERAEMIA 8 0.0002
958 ASTHMA 19 0.0002
959 INFUSION RELATED REACTION 11 0.0002
960 SKIN EXFOLIATION 14 0.0002
961 CORONARY ARTERY DISEASE 5 0.0002
962 HAEMATOCHEZIA 9 0.0002
963 EYE IRRITATION 9 0.0002
964 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
965 NIGHT SWEATS 5 0.0002
966 BLOOD CREATININE INCREASED 10 0.0002
967 HAEMORRHAGE 15 0.0001
968 LUNG DISORDER 7 0.0001
969 INJURY 10 0.0001
970 AGGRESSION 7 0.0001
971 HYPERGLYCAEMIA 5 0.0001
972 PROSTATE CANCER 11 0.0001
973 HAEMOGLOBIN DECREASED 14 0.0001
974 HOSPITALISATION 19 0.0001
975 CONVULSION 7 0.0001
976 FEBRILE NEUTROPENIA 8 0.0001
977 INTENTIONAL OVERDOSE 7 0.0001
978 FLATULENCE 6 0.0001
979 BLOOD GLUCOSE DECREASED 5 0.0001
980 WHEEZING 6 0.0001
981 CARDIAC FAILURE CONGESTIVE 8 0.0001
982 BLOOD GLUCOSE INCREASED 18 0.0001
983 EMOTIONAL DISTRESS 11 0.0001
984 OVERDOSE 18 0.0001
985 NO ADVERSE EVENT 12 0.0001
986 CHRONIC KIDNEY DISEASE 5 0.0001
987 INJECTION SITE BRUISING 5 0.0001
988 ACUTE KIDNEY INJURY 7 0.0000
989 TOXICITY TO VARIOUS AGENTS 7 0.0000
990 INJECTION SITE PAIN 11 0.0000